Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “These alarming estimates lay bare just how urgently investment in...

24 September 2021

Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “It is fantastic to see that trastuzumab deruxtecan (...

19 September 2021

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Lung cancer patients today received welcome news of interim access to a...

10 September 2021

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “These revelations paint a really frightening...

8 September 2021

The National Institute for Health and Care Excellence (NICE) has today (Thursday 12th August 2021) announced its decision to approve abemaciclib with...

12 August 2021

The National Institute for Health and Care Excellence (NICE) has today (Thursday 12th August 2021) announced its decision to approve abemaciclib with...

12 August 2021

Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said: “Each year in the UK around 55,000 women are diagnosed...

22 July 2021

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “The Cancer Drugs Fund has already changed the lives of thousands of...

21 July 2021

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “The 11% vacancy rate for breast consultant clinical oncologists across...

14 July 2021